Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: Report of two patients with hidradenocarcinoma and trichoblastic carcinoma

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 2, 2010, Pages 199-203

  Battistella, M ^a   Mateus, C ^a   Lassau, N ^b   Chami, L ^b   Boukoucha, M ^b   Duvillard, P ^b   Cribier, B ^c   Robert, C ^a  

^a Dermatology Unit   (Italy)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Adnexal carcinoma; Contrast enhanced ultrasonography; Metastasis; Sunitinib; Tyrosine kinase inhibitor

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; SUNITINIB;

ADNEXA DISEASE; ADULT; ARTICLE; CASE REPORT; CERVICAL SPINE; CONTRAST ENHANCEMENT; DRUG EFFICACY; DRUG TOLERANCE; EDEMA; FATIGUE; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTHYROIDISM; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NERVE ROOT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PRIORITY JOURNAL; RADIATION DOSE; SKIN CARCINOMA; SKIN DISCOLORATION; SKIN TUMOR; SWEAT GLAND CARCINOMA; TREATMENT RESPONSE; TRICHILEMMOMA; TRICHOBLASTIC CARCINOMA; TUMOR BLOOD FLOW; TUMOR VOLUME; ULTRASOUND;

ACROSPIROMA; ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PYRROLES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 74549143750     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03301.x     Document Type: Article

References (11)

1. Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms - Part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol 2007 60 : 145 159. (Pubitemid 46245778)
2. Morris DM, Sanusi ID, Lanehart WH. Carcinoma of eccrine sweat gland: experience with chemotherapy, autopsy findings in a patient with metastatic eccrine carcinoma, and a review of the literature. J Surg Oncol 1986 31 : 26.
3. Cooley CJ, Kelsen DP, Huvos AG et al. Chemotherapy of metastatic sweat gland carcinoma. Retrospective review. Am J Clin Oncol 1985 8 : 307 311.
4. Chow LQM, Gail Eckhardt S. Sunitinib: from rational design to clinical efficacy. J Clin Oncol 2007 25 : 884 896.
5. Ko CJ, Cochran AJ, Eng W, Binder SW. Hidradenocarcinoma: a histological and immunohistochemical study. J Cutan Pathol 2006 33 : 726 730.
6. Regauer S, Beham-Schmid C, Okcu M et al. Trichoblastic carcinoma (« malignant trichoblastoma ») with lymphatic and hematogenous metastases. Mod Pathol 2000 13 : 673 678.
7. Faivre S, Delbaldo C, Vera K et al. Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 2006 24 : 25 35.
8. Motzer RJ, Rini BI, Michaelson MD et al. Phase 2 trials of SU11248 show antitumor activity in second-line therapy in patients with metastatic renal cell carcinoma (RCC). J Clin Oncol 2005 23 : 380s.
9. Lassau N, Chami L, Benatsou B et al. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol Suppl 2007 17 : F89 F98.
10. Lassau N, Lamuraglia M, Chami L et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol 2006 187 : 1267 1273.
11. Lamuraglia M, Escudier B, Chami L et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound. Eur J Cancer 2006 42 : 2472 2479.